GSK's (LSE: GSK) five-in-one vaccine approved by the FDA

GSK's five-in-one meningococcal vaccine, Penmenvy, has been approved by the US FDA for the treatment of meningitis, an indication that, in extreme cases, can lead to deadly brain swelling. More specifically, Penmenvy combines two components of two marketed inoculations (Bexsero and Menveo), protecting ...

Den vollständigen Artikel lesen ...